NCT05667493: An ongoing trial by Ionis Pharmaceuticals, Inc.
This trial is ongoing. It must report results 4 years, 1 month from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05667493 |
|---|---|
| Title | An Open-Label Extension Study to Assess the Long-Term Safety of Eplontersen (ION-682884) in Patients With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 30, 2022 |
| Completion date | Aug. 31, 2029 |
| Required reporting date | Aug. 31, 2030, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | July 3, 2026 |
| Days late | None |